AG˹ٷ

STOCK TITAN

[Form 4] Olaplex Holdings, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Olaplex (NASDAQ: OLPX) filed a routine Form 4 on June 29, 2025. The filing states that former director Paula Zusi ceased serving on the board effective June 10, 2025 and is therefore no longer subject to Section 16 reporting requirements. No purchases, sales, or other equity transactions were disclosed, and the tables for both non-derivative and derivative securities list no entries. The document is filed voluntarily to formally register Ms. Zusi’s change in reporting status.

Because the Form 4 reports no share transactions or monetary amounts, it represents an administrative update rather than a market-moving event.

Olaplex (NASDAQ: OLPX) ha presentato una Form 4 ordinaria il 29 giugno 2025. Nel documento si comunica che l'ex direttrice Paula Zusi ha cessato il suo incarico nel consiglio di amministrazione a partire dal 10 giugno 2025 e pertanto non è più soggetta agli obblighi di segnalazione ai sensi della Sezione 16. Non sono state dichiarate acquisizioni, vendite o altre operazioni su titoli, e le tabelle relative sia ai titoli non derivati che a quelli derivati risultano vuote. Il documento è stato depositato volontariamente per registrare formalmente il cambiamento dello status di segnalazione della signora Zusi.

Poiché la Form 4 non riporta transazioni azionarie o importi monetari, si tratta di un aggiornamento amministrativo e non di un evento in grado di influenzare il mercato.

Olaplex (NASDAQ: OLPX) presentó un Formulario 4 rutinario el 29 de junio de 2025. En el documento se indica que la ex directora Paula Zusi dejó de formar parte del consejo a partir del 10 de junio de 2025 y, por lo tanto, ya no está sujeta a los requisitos de reporte de la Sección 16. No se revelaron compras, ventas ni otras transacciones de acciones, y las tablas tanto de valores no derivados como derivados no contienen entradas. El documento se presenta de manera voluntaria para registrar formalmente el cambio en el estado de reporte de la Sra. Zusi.

Dado que el Formulario 4 no reporta transacciones de acciones ni montos monetarios, representa una actualización administrativa más que un evento que pueda afectar el mercado.

Olaplex (NASDAQ: OLPX)� 2025� 6� 29� 정기 Form 4� 제출했습니다. 제출서에 따르� � 이사 Paula Zusi� 2025� 6� 10일부� 이사회에� 물러났으�, 이에 따라 섹션 16 보고 의무 대상이 아니� 되었습니�. 매수, 매도 또는 기타 주식 거래 내역은 공개되지 않았으며, 비파� � 파생 증권 � 모두� 거래 내역� 없습니다. � 문서� Zusi 씨의 보고 상태 변경을 공식적으� 등록하기 위해 자발적으� 제출되었습니�.

Form 4� 주식 거래� 금전� 금액� 보고되지 않았� 때문�, 이는 시장� 영향� 미치� 사건이라기보다는 행정� 업데이트� 해당합니�.

Olaplex (NASDAQ : OLPX) a déposé un Formulaire 4 de routine le 29 juin 2025. Le dépôt indique que l'ancienne administratrice Paula Zusi a cessé ses fonctions au conseil d'administration à compter du 10 juin 2025 et n'est donc plus soumise aux obligations de déclaration en vertu de la Section 16. Aucun achat, vente ou autre transaction sur actions n'a été divulgué, et les tableaux pour les titres non dérivés et dérivés ne comportent aucune entrée. Le document est déposé volontairement afin d'enregistrer formellement le changement de statut déclaratif de Mme Zusi.

Étant donné que le Formulaire 4 ne rapporte aucune transaction d'actions ni montant monétaire, il s'agit d'une mise à jour administrative plutôt que d'un événement susceptible d'influencer le marché.

Olaplex (NASDAQ: OLPX) reichte am 29. Juni 2025 routinemäßig ein Formular 4 ein. Die Einreichung besagt, dass die ehemalige Direktorin Paula Zusi mit Wirkung zum 10. Juni 2025 aus dem Vorstand ausgeschieden ist und daher nicht mehr den Meldepflichten gemäß Abschnitt 16 unterliegt. Es wurden keine Käufe, Verkäufe oder sonstigen Aktiengeschäfte offengelegt, und die Tabellen für nicht-derivative sowie derivative Wertpapiere enthalten keine Einträge. Das Dokument wird freiwillig eingereicht, um Frau Zusis Änderung im Meldepflichtstatus formal zu registrieren.

Da das Formular 4 keine Aktiengeschäfte oder Geldbeträge meldet, handelt es sich um ein administratives Update und nicht um ein marktrelevantes Ereignis.

Positive
  • None.
Negative
  • None.

Olaplex (NASDAQ: OLPX) ha presentato una Form 4 ordinaria il 29 giugno 2025. Nel documento si comunica che l'ex direttrice Paula Zusi ha cessato il suo incarico nel consiglio di amministrazione a partire dal 10 giugno 2025 e pertanto non è più soggetta agli obblighi di segnalazione ai sensi della Sezione 16. Non sono state dichiarate acquisizioni, vendite o altre operazioni su titoli, e le tabelle relative sia ai titoli non derivati che a quelli derivati risultano vuote. Il documento è stato depositato volontariamente per registrare formalmente il cambiamento dello status di segnalazione della signora Zusi.

Poiché la Form 4 non riporta transazioni azionarie o importi monetari, si tratta di un aggiornamento amministrativo e non di un evento in grado di influenzare il mercato.

Olaplex (NASDAQ: OLPX) presentó un Formulario 4 rutinario el 29 de junio de 2025. En el documento se indica que la ex directora Paula Zusi dejó de formar parte del consejo a partir del 10 de junio de 2025 y, por lo tanto, ya no está sujeta a los requisitos de reporte de la Sección 16. No se revelaron compras, ventas ni otras transacciones de acciones, y las tablas tanto de valores no derivados como derivados no contienen entradas. El documento se presenta de manera voluntaria para registrar formalmente el cambio en el estado de reporte de la Sra. Zusi.

Dado que el Formulario 4 no reporta transacciones de acciones ni montos monetarios, representa una actualización administrativa más que un evento que pueda afectar el mercado.

Olaplex (NASDAQ: OLPX)� 2025� 6� 29� 정기 Form 4� 제출했습니다. 제출서에 따르� � 이사 Paula Zusi� 2025� 6� 10일부� 이사회에� 물러났으�, 이에 따라 섹션 16 보고 의무 대상이 아니� 되었습니�. 매수, 매도 또는 기타 주식 거래 내역은 공개되지 않았으며, 비파� � 파생 증권 � 모두� 거래 내역� 없습니다. � 문서� Zusi 씨의 보고 상태 변경을 공식적으� 등록하기 위해 자발적으� 제출되었습니�.

Form 4� 주식 거래� 금전� 금액� 보고되지 않았� 때문�, 이는 시장� 영향� 미치� 사건이라기보다는 행정� 업데이트� 해당합니�.

Olaplex (NASDAQ : OLPX) a déposé un Formulaire 4 de routine le 29 juin 2025. Le dépôt indique que l'ancienne administratrice Paula Zusi a cessé ses fonctions au conseil d'administration à compter du 10 juin 2025 et n'est donc plus soumise aux obligations de déclaration en vertu de la Section 16. Aucun achat, vente ou autre transaction sur actions n'a été divulgué, et les tableaux pour les titres non dérivés et dérivés ne comportent aucune entrée. Le document est déposé volontairement afin d'enregistrer formellement le changement de statut déclaratif de Mme Zusi.

Étant donné que le Formulaire 4 ne rapporte aucune transaction d'actions ni montant monétaire, il s'agit d'une mise à jour administrative plutôt que d'un événement susceptible d'influencer le marché.

Olaplex (NASDAQ: OLPX) reichte am 29. Juni 2025 routinemäßig ein Formular 4 ein. Die Einreichung besagt, dass die ehemalige Direktorin Paula Zusi mit Wirkung zum 10. Juni 2025 aus dem Vorstand ausgeschieden ist und daher nicht mehr den Meldepflichten gemäß Abschnitt 16 unterliegt. Es wurden keine Käufe, Verkäufe oder sonstigen Aktiengeschäfte offengelegt, und die Tabellen für nicht-derivative sowie derivative Wertpapiere enthalten keine Einträge. Das Dokument wird freiwillig eingereicht, um Frau Zusis Änderung im Meldepflichtstatus formal zu registrieren.

Da das Formular 4 keine Aktiengeschäfte oder Geldbeträge meldet, handelt es sich um ein administratives Update und nicht um ein marktrelevantes Ereignis.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zusi Paula

(Last) (First) (Middle)
C/O OLAPLEX HOLDINGS, INC.
432 PARK AVENUE SOUTH, THIRD FLOOR

(Street)
NEW YORK NY 10016

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OLAPLEX HOLDINGS, INC. [ OLPX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
See Remarks.
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
The Reporting Person no longer serves as a Director of the Issuer effective June 10, 2025. This Form 4 is being filed voluntarily, solely to state that as a result, the Reporting Person is no longer subject to Section 16 in connection with the securities of the Issuer.
/s/ John Duffy, attorney-in-fact 06/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Why did Paula Zusi file a Form 4 for Olaplex (OLPX) on June 29 2025?

The filing notes she resigned as a director on June 10 2025 and is thus no longer subject to Section 16 reporting obligations.

Did Paula Zusi buy or sell any Olaplex shares in this Form 4?

No. The Form 4 reports no acquisitions or dispositions of either non-derivative or derivative securities.

Is Paula Zusi still on the Olaplex board?

No. The Form 4 states she ceased serving as a director effective June 10 2025.

Does the Form 4 mention a Rule 10b5-1 trading plan?

The form includes a checkbox reference to Rule 10b5-1, but no transaction was reported under such a plan.
Olaplex Holdings, Inc.

NASDAQ:OLPX

OLPX Rankings

OLPX Latest News

OLPX Latest SEC Filings

OLPX Stock Data

872.36M
138.56M
0.56%
98.22%
1.35%
Specialty Retail
Perfumes, Cosmetics & Other Toilet Preparations
United States
NEW YORK